The wide standard deviation and the presence of a maximum pre-biopsy PSA level of 100.00 ng/mL suggest that a subset of patients exhibited markedly elevated PSA values, potentially indicative of higher tumor burden, larger lesion volume, or increased inflammatory activity within the prostate. Here, KLK3 is linked to neoplasm.